Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Therapeutic Potential of the Microbiome"
A special issue of Medical Sciences (ISSN 2076-3271).
Deadline for manuscript submissions: closed (28 February 2019).
Internist, Gastroenterologist, Head of Department of Internal Medicine, Thuringia-Clinic Saalfeld; Georgius Agricola GmbH, Teaching Hospital of the University of Jena, 07318 Saalfeld, Rainweg 68
Interests: microbiome; fecal microbiote therapy; irritable bowel syndrome
In recent years, the gut microbiota has been extensively studied and has emerged as a promising therapy of gastrointestinal and extra-gastrointestinal diseases.
The human gut microbiota constitutes a very complex ecosystem containing approximately 1014 microorganisms belonging to more than 1000 species. It consists mostly of bacteria, but fungi, viruses and protozoa can also frequently be detected in the gut. The gut microbiota has important functions for human health. The pathologic alteration of its composition, termed dysbiosis, has been linked to multiple gastrointestinal (Clostridium difficile colitis, inflammatory bowel disease, irritable bowel syndrome, etc.) and non-gastrointestinal diseases (obesity, metabolic syndrome, neuropsychiatric diseases, etc.).
Modulation of the gut microbiota with fecal microbiota transplantation (FMT) is highly effective for treating Clostridium difficile infection (FDI). Recent studies also suggest that the intestinal microbiome is involved in the pathogenesis of several chronic diseases, such as obesity, type 2 diabetes, cardiovascular, cancer or inflammatory bowel disease, and irritable bowel syndrome. In fact, the manipulation of fecal microbiota to treat inflammatory bowel disease and irritable bowel syndrome is being studied. There is also evidence that targeting gut microbiota through dietary interventions could be a potential therapeutic approach.
On these grounds, in this Special Issue of Medical Sciences we welcome research articles, reviews and communications to present the most recent advances in the study of the therapeutic potential of the microbiome.
Prof. Peter C. Konturek
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medical Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.